AcclaimIP-ad

Match Document Document Title
US20120282300 PROTEIN BIOMATERIALS AND BIOCOACERVATES AND METHODS OF MAKING AND USING THEREOF  
The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention...
US20130280229 Stabilisation of Proteins  
A dry composition for use in therapy or diagnosis, obtainable by drying an aqueous composition comprising a protein and one or more displacement buffers, wherein the pH of the aqueous composition...
US20110033549 Stabilisation of Proteins  
A dry composition for use in therapy or diagnosis, obtainable by drying an aqueous composition comprising a protein and one or more displacement buffers, wherein the pH of the aqueous composition...
US20150164782 TOPICAL COMPOSITION FOR TREATMENTOF SKIN, HAIR, AND/OR NAILS AND METHOD OF USING THE SAME  
A topical composition includes an amount of a concentrate derived from Ecklonia marima (sea kelp) effective for treating the skin, hair and/or nails and a dermatologically acceptable carrier.
US20150071903 USE OF CATIONIC LIPIDS TO DELIVER CAS9  
Compositions, methods, strategies, kits, and systems for the supercharged protein-mediated delivery of functional effector proteins into cells in vivo, ex vivo, or in vitro are provided....
US20140134148 Brucella Abortus Proteins and Methods of Use Thereof  
Compositions and methods for the diagnosis and prevention of B. abortus infection are provided.
US20150071879 Stabilization of Aqueous Compositions of Proteins with Displacement Buffers  
An aqueous composition having increased protein stability is obtained by: a. determining a pH at which the protein has stability at the desired temperature; b. adding to the composition at least...
US20130017260 ORAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF HUMAN CANITIES  
The present application relates generally to oral pharmaceutical formulations for the treatment of human canities.
US20100330013 AMADORIASES IN WASHING AND CLEANING PRODUCTS  
Body care products, hair care products, shampoos, oral care, dental care and dental prosthesis care products, dental brace care products, cosmetics, therapeutics, washing agents, cleaning agents,...
US20110229449 PROPHYLAXIS AND TREATMENT OF MACULAR DEGENERATION AND RETINOPATHY USING A PRDX PROTEIN  
The present invention provides an agent for the prophylaxis or treatment of retinopathy or AMD containing PRDX 5 or PRDX 6, as well as an agent for the prophylaxis or treatment of retinopathy or...
US20130216479 SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS  
Site-specific modifications of proteins at their N-termini are provided. In particular, a chemical modification of proteins at their N-termini via a transamination reaction to form homogeneous...
US20120328594 PROTEIN AND LIPID BIOMARKERS PROVIDING CONSISTENT IMPROVEMENT TO THE PREDICTION OF TYPE 2 DIABETES  
The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will...
US20110150943 ADHESIVE FOR MEDICAL APPLICATIONS AND MEANS FOR HAEMOSTASIS  
The invention relates to adhesives for medical applications and methods of their preparation and use.
US20120058099 USE OF HYPOXANTHINE FOR PROMOTION OF NEURONAL OUTGROWTH  
Disclosed herein is a method of promoting neuronal outgrowth in a neuron. The method comprises contacting the neuron with an effective amount of hypoxanthine, to thereby promote neuronal outgrowth...
US20130052236 COMPOSITE POLYLACTIC ACID/ALGINATE SURGICAL BARRIER  
The present disclosure provides a medical assembly comprising a surgical barrier aspect comprising polylactic acid, and a hydrophilic mucoadhesive aspect, wherein the surgical barrier aspect is...
US20100316623 PHENYLALANINE HYDROXYLASE FUSION PROTEIN AND METHODS FOR TREATING PHENYLKETONURIA  
The present invention provides Phenylalanine Hydroxylase (PAH) fusion proteins and pharmaceutical compositions comprising the same, as well as encoding polynucleotides and vectors, and methods for...
US20110081421 METHODS OF REGULATING RENALASE (MONOAMINE OXIDASE C)  
The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase...
US20140065170 DIAGNOSIS AND TREATMENT OF PREECLAMPSIA  
The present invention relates to biomarkers for preeclampsia as well as treatment of this disease. In particular, the invention relates to methods for diagnosis or aiding in the diagnosis of...
US20110177054 USE OF ENDO-LYSOSOMAL SYSTEM AND SECRETED VESICLES (EXOSOME-LIKE) IN TREATMENTS AND DIAGNOSTICS BASED ON SMALL RNA AND EXPERIMENTAL STUDY OF SMALL RNA  
The present invention relates to a method for determining the delivery rates and/or efficiency of a siRNA, miRNA or related molecule to target organs or cells, a kit and the use of proteins or...
US20080044399 Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype  
This invention relates to methods and compositions of determining the benefit of therapy using vitamin-E for the treatment of cardiovascular events in individuals with diabetes melitus based on...
US20130295074 Pyridoxamine for the Treatment of Diabetic Kidney Disease  
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and...
US20130011379 Pyridoxamine for the Treatment of Diabetic Kidney Disease  
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and...
US20130183281 METHODS AND COMPOSITONS FOR CELL-PROLIFERATION-RELATED DISORDERS  
Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
US20120093802 BIOACTIVE COMPOSITION INCLUDING STABILIZED PROTEIN AND PROCESS FOR PRODUCING THE SAME  
A bioactive composition includes a porous hydrogel matrix. At least one protein is immobilized in the porous hydrogel matrix forming a hydrogel protein composite that is stable in an organic...
US20150064158 SENSE-IMPROVING AGENT  
A purpose of the present invention is to provide a sense-improving agent which is safe and, when routinely taken or applied to the skin, exerts an effect of improving deterioration in peripheral...
US20140004180 TOPICAL COMPOSITIONS COMPRISING DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH HIGH HISTAMINE LEVELS WHICH INVOLVE AN INCREASE IN PAIN  
The present invention relates to a pharmaceutical, cosmetic or dermo-cosmetic composition that comprises DAO, for use in the prevention or treatment of diseases or pathological conditions...
US20150157771 Soluble Coating Comprising Polyelectrolyte With Hydrophobic Counterions  
The present invention provides an implantable device having a biosoluble coating comprising a polyelectrolyte and a counterion and the methods of making and using the same.
US20140335069 GLUCOSE-6-PHOSPHATE DEHYDROGENASE ASSAYS  
Aspects of embodiments may include methods for automated enzymatic detection of glucose-6-phosphate dehydrogenase (G6PD) activity. Aspects of embodiments may include methods for enzymatic...
US20140140975 TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS  
The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress...
US20100298628 STRESS URINARY INCONTINENCE TREATMENT  
A method for stabilizing a urethra in a female patient having stress urinary incontinence caused by stretching of a pubourethral ligament includes filling a substantial portion of the pubourethral...
US20140370072 PROHEALING PIEZOELECTRIC COATINGS  
Provided herein is a prohealing piezoelectric coating and the method of making and using the same.
US20140255362 SRPX FOR TREATMENT OF CANCER  
Methods of treating a tumor in a subject include identifying a subject having, at risk for, or suspected of having a tumor, and administering to the subject an effective amount of an SRPX.
US20140335068 NOVEL USE OF EC-SOD FOR TREATING ANGIOGENESIS-MEDIATED EYE DISEASES  
A method for treating an angiogenesis-mediated eye disease, includes administering to a subject in need thereof an effective amount of EC-SOD protein, or a vector having a polynucleotide encoding...
US20140127180 MUTANT CYTOCHROME P450 2B6 PROTEINS AND USES THEREOF  
The present invention to relates mutant human cytochrome P450 2B6 (CYP2B6) proteins, and fusion proteins comprising said mutant CYP2B6 proteins. In particular, fusion proteins comprising mutant...
US20150023949 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER  
Methods for treatment and diagnosis of pervasive developmental disorders in humans are described.
US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION  
Improvements on the basic method used for BEAMing increase sensitivity and increase the signal-to-noise ratio. The improvements have permitted the determination of intrinsic error rates of various...
US20110008310 METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY  
The invention features methods, kits, and compositions for mitochondrial replacement in the treatment of disorders arising from mitochondrial dysfunction. The invention also features methods of...
US20120093796 NOVEL USE OF EC-SOD AND METHOD FOR PREPARING THEREOF  
The present invention relates to compositions for preventing or treating angiogenesis-mediated diseases or allergic diseases which contain, as an active ingredient, an EC-SOD protein or a vector...
US20130089534 METHODS FOR ASSISTING ANTI-CANCER DRUGS  
A method for assisting an anti-cancer drug comprising administrating an effective amount of Antrodia camphorata fermentation solution to improve life quality of patient suffering from cancers...
US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof  
The present invention relates to the uses of the protein PRG4 and therapeutic modulation thereof. In particular, the present invention relates compositions and methods utilizing PRG4 and...
US20120093914 IMPLANTABLE LIPOSOME EMBEDDED MATRIX COMPOSITION, USES THEREOF, AND POLYCAPROLACTONE PARTICLES AS SCAFFOLDS FOR TISSUE REGENERATION  
In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to...
US20150246101 METHODS FOR ALLEVIATING SYMPTOMS OF MULTIPLE SCLEROSIS BASED ON APOAEQUORIN-CONTAINING COMPOSITIONS  
Methods for alleviating symptoms related to Multiple Sclerosis by administration of apoaequorin are provided by the present invention. Such symptoms include, for example, sleep quality, energy...
US20150174181 HERBAL EXTRACT AND A METHOD OF TREATING LUNG TUMOR THEREOF  
The invention discloses an herbal extract of treating lung tumor. The herbal extract comprises Antrodia cinnamomea and Cordyceps militaris, and the herbal extract is manufactured as following:...
US20110300109 COMPOSITIONS AND METHODS FOR TREATING CANCER  
The present invention is based, in part, on our discovery of compositions and methods that can be used to systemically deplete arginine and thereby treat arginine-dependent cancers. Our studies...
US20110176994 Buoyant Polymer Particles for Delivery of Therapeutic Agents to the Central Nervous System  
The invention provides compositions and methods for treating a subject who has suffered from a central nervous system disorder. More particularly, the invention provides sustained polymeric drug...
US20080279840 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma  
A histaminase of vegetable origin to be used in the treatment of allergic and septic shock and in allergic asthma, and the preparation of the histaminase for pharmaceutical use and the...
US20130004477 Methods for Treating Inflammation and Oxidative Stress Related Diseases  
This invention provides compositions and methods for treating inflammation related diseases. Particularly, the present invention provides methods and compositions of administering thiocyanate to...
US20140212492 Oral Enzyme Compositions for Intestinal Delivery  
The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme...
US20120195873 METHODS OF ATTENUATING THE LOSS OF FUNCTIONAL STATUS  
Nutritional compositions and methods of using the nutritional compositions with exercise to attenuate the loss of functional status are provided. In a general embodiment, the present disclosure...
US20130034529 NATURAL COMPOSITIONS AND METHODS OF PROMOTING WOUND HEALING  
Compositions comprising honey, myrhh, and Nigella Sativa seeds are described. The honey:myrrh:N. sativa seed ratio can be 100:0.5-50:0.1-10, based on weight. The compositions can also comprise one...